Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 5/20 | 0.65 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.65 |
| ▸ | CTSK | P43235 | 5/20 | 0.64 |
| ▸ | CTSB | P07858 | 4/20 | 0.64 |
| ▸ | CTSS | P25774 | 2/20 | 0.64 |
| ▸ | CTSF | Q9UBX1 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23824249 | 0.95 | CTSL (0.72) | CTSLCAPN1CTSKCTSBCTSS | |
| SCHEMBL23824250 | 0.95 | CTSL (0.72) | CTSLCAPN1CTSKCTSBCTSS | |
| SCHEMBL34468071 | 0.95 | CTSL (0.72) | CTSLCAPN1CTSKCTSBCTSS | |
| SCHEMBL22750618 | 0.93 | CTSL (0.67) | CTSLCAPN1CTSKCTSBCTSS | |
| SCHEMBL22750619 | 0.93 | CTSL (0.67) | CTSLCAPN1CTSKCTSBCTSS | |
| SCHEMBL22750617 | 0.93 | CTSL (0.67) | CTSLCAPN1CTSKCTSBCTSS | |
| SCHEMBL24583604 | 0.92 | CTSL (0.66) | CTSLCAPN1CTSKCTSBCTSS | |
| SCHEMBL25764269 | 0.91 | CTSL (0.56) | CTSLCAPN1CTSKCTSBCTSS | |
| SCHEMBL23824397 | 0.90 | CTSL (0.64) | CTSLCAPN1CTSKCTSBCTSS | |
| SCHEMBL23824393 | 0.90 | CTSL (0.64) | CTSLCAPN1CTSKCTSBCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022133588-A1 | RNA VIRUS INHIBITOR COMPOUNDS AND USES THEREOF | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022133588-A1 | RNA VIRUS INHIBITOR COMPOUNDS AND USES THEREOF | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2022-06-30 | — | — | WO | disclosed |
| US-20220204476-A1 | RNA VIRUS INHIBITOR COMPOUNDS AND USES THEREOF | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2022-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220204476-A1 | RNA VIRUS INHIBITOR COMPOUNDS AND USES THEREOF | SARS1, NSUN3, GTF3C4 | CTSL 539/4885CAPN1 469/4885CTSK 719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.